1. Home
  2. EZPW vs TBPH Comparison

EZPW vs TBPH Comparison

Compare EZPW & TBPH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo EZCORP Inc. Non Voting

EZPW

EZCORP Inc. Non Voting

HOLD

Current Price

$21.08

Market Cap

1.1B

ML Signal

HOLD

Logo Theravance Biopharma Inc.

TBPH

Theravance Biopharma Inc.

HOLD

Current Price

$18.12

Market Cap

993.7M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
EZPW
TBPH
Founded
1989
2013
Country
United States
United States
Employees
N/A
N/A
Industry
Other Specialty Stores
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.1B
993.7M
IPO Year
1991
N/A

Fundamental Metrics

Financial Performance
Metric
EZPW
TBPH
Price
$21.08
$18.12
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
4
5
Target Price
$21.00
$27.80
AVG Volume (30 Days)
1.3M
516.8K
Earning Date
11-13-2025
11-10-2025
Dividend Yield
N/A
N/A
EPS Growth
28.89
N/A
EPS
1.42
0.58
Revenue
$1,274,280,000.00
$80,327,000.00
Revenue This Year
$11.91
$70.78
Revenue Next Year
$7.78
N/A
P/E Ratio
$14.83
$31.31
Revenue Growth
9.70
27.12
52 Week Low
$11.56
$7.90
52 Week High
$21.49
$20.33

Technical Indicators

Market Signals
Indicator
EZPW
TBPH
Relative Strength Index (RSI) 78.89 54.58
Support Level $19.86 $17.25
Resistance Level $21.49 $20.32
Average True Range (ATR) 0.56 0.73
MACD 0.20 -0.28
Stochastic Oscillator 88.72 30.62

Price Performance

Historical Comparison
EZPW
TBPH

About EZPW EZCORP Inc. Non Voting

EZCORP Inc is a United States-based company engaged in offering pawn loans in the United States and Mexico. It also offers short-term unsecured loans and other consumer financial products, and buys and sells second-hand goods. The operating segments of the company are U.S. Pawn, Latin America Pawn, and Other Investments. The U.S. Pawn segment includes all pawn activities in the United States. The Latin America Pawn segment includes all pawn activities in Mexico and other parts of Latin America. The company generates revenue from merchandise sales, jewelry scrapping sales, and pawn service charges, of which key revenue is derived from the merchandise sales, which are mainly collateral forfeited from pawn lending operations and used merchandise purchased from the customers.

About TBPH Theravance Biopharma Inc.

Theravance Biopharma Inc is a diversified biopharmaceutical company focused on the discovery, development, and commercialization of organ-selective medicines. Its purpose is to pioneer a new generation of small-molecule drugs designed to meet patient needs. Its research is focused on the areas of inflammation and immunology. The firm applies organ-selective expertise to target disease biologically, to discover and develop medicines that may expand the therapeutic index with the goal of maximizing efficacy and limiting systemic side effects. The company develops lung-selective medicines to treat respiratory disease, including FDA-approved YUPELRI (revefenacin) inhalation solution indicated for the maintenance treatment of patients with chronic obstructive pulmonary disease (COPD).

Share on Social Networks: